Empowering appropriate antimicrobial use with rapid diagnostics.

The Consequences

According to the IDSA/ATS CAP guidelines, empiric treatment of L. pneumophila is recommended using a macrolide or respiratory fluoroquinolone for every patient with community-acquired pneumonia. In one study, 11.2% of patients with L. pneumophila pneumonia received inappropriate empirical antibiotic therapy at hospital admission. Significantly, inappropriate empirical antibiotic therapy has been associated with early failure and higher mortality in patients with CAP.1